We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. What is obesity - epidemiology
- Prof. Alexandra Blakemore
-
2. What is obesity - definition
- Dr. Andrew Walley
-
3. What is obesity - physiology
- Prof. Alexandra Blakemore
-
4. Obesity: the role of fetal programming
- Dr. Jess Buxton
-
5. Childhood obesity
- Dr. Mars Skae
-
6. Dysregulated eating behaviour, eating disorders and obesity
- Prof. Ulrike Schmidt
-
7. Adipose tissue biology
- Dr. Constantinos Christodoulides
-
9. Obesity and asthma
- Prof. Anne Dixon
-
10. Obesity and women’s health 1: female obesity
- Dr. Thomas Barber
-
11. Obesity and women’s health 2: polycystic ovary syndrome
- Dr. Thomas Barber
-
12. Obesity and psychology
- Dr. Samantha Scholtz
-
13. Hormones, feeding and animal models
- Prof. Carel le Roux
-
14. Obesity and the hedonic response 1
- Dr. Tony Goldstone
-
15. Obesity and the hedonic response 2
- Dr. Tony Goldstone
-
16. Genetics of monogenic obesity 1
- Prof. Dr. Johannes Hebebrand
- Prof. Dr. Anke Hinney
-
17. Genetics of monogenic obesity 2
- Prof. Dr. Johannes Hebebrand
- Prof. Dr. Anke Hinney
-
18. Genetic epidemiology of obesity 1
- Prof. Ruth Loos
-
19. Genetic epidemiology of obesity 2
- Prof. Ruth Loos
-
20. Metabolic communication in development and control of obesity 1
- Prof. Elaine Holmes
-
21. Metabolic communication in development and control of obesity 2
- Prof. Elaine Holmes
-
22. Obesity management: lifestyle and bariatric surgery 1
- Prof. John Wilding
-
23. Obesity management: lifestyle and bariatric surgery 2
- Prof. John Wilding
-
24. Obesity, present and future therapies
- Prof. Sir Stephen Bloom
-
25. Pharmacotherapy for obesity: why it is needed
- Prof. Joe Proietto
-
27. Towards personalised medicine in obesity
- Prof. Alexandra Blakemore
Printable Handouts
Navigable Slide Index
- Introduction
- Outcomes that matter to patients
- Functional & QoL outcomes: diet & physiotherapy
- Example service outcomes – beyond weight loss
- The gap between lifestyle interventions & surgery
- Current & future obesity pharmacotherapy
- Severe obesity (BMI>40) is very common
- Bariatric surgery procedures
- Bariatric surgery – effective for weight loss
- SOS study outcomes
- Bariatric surgery, diabetes prevention: SOS study
- Effect of bariatric surgery on diabetes outcomes
- T2DM: RCT of surgery vs. medical therapy
- SOS cardiovascular events in diabetes
- Diabetes remission relates to duration
- Does surgery improve sleep apnoea? (1)
- Does surgery improve sleep apnoea? (2)
- Limitations and adverse effects of bariatric surgery
- Morbidity after bariatric surgery is not trivial
- NICE guidelines on bariatric surgery in T2DM
- Peri-operative management and follow up
- Follow up care packages after bariatric surgery
- Summary & conclusions
Topics Covered
- Obesity outcomes that matter to patients
- Options beyond lifestyle: pharmacotherapy and bariatric surgery
- Effects of bariatric surgeries on obesity co-morbidities
- Bariatric surgery: limitations, adverse effects and follow up
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Wilding, J. (2015, December 31). Obesity management: lifestyle and bariatric surgery 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/LKJO8120.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. John Wilding, Consultant: Novo Nordisk, Orexigen; Speaker's Bureau: Novo Nordisk, Orexigen; Grant/Research Support (Principal Investigator): Novo Nordisk
Obesity management: lifestyle and bariatric surgery 2
Published on December 31, 2015
28 min
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:05
It's important to remember
that the goal of any
weight loss program
is not just
to achieve weight loss.
When we ask patients
what they're worried about,
it's not just the body weight,
it's whether
their ability to function
is going to be improved
by weight loss.
The pain, the disability,
perhaps discrimination
in the handicap,
whether their disease
is going to be improved,
their diabetes risk,
their cardiovascular disease,
sleep apnea,
their risk of cancer,
and for some,
some of the body image problems
and psychological problems
that are associated
with their weight are in fact
the primary concern.
For that reason,
when we evaluate our programs,
we're not just looking
at weight loss,
we're also looking at some
of these other outcomes
that matter to patients
and I'd like to just share
with you some
of the outcomes that we use
and how our weight loss program
is able to improve
some of these outcomes.
1:07
So, if we look at some
of the functional
and quality of life outcomes
that we use,
these data are looking
at step tests,
6 meter walk tests,
and sit to stand.
And you can see that all
of these improve during
the intensive part
of our physiotherapy program.
The Measure Yourself Medical
Outcomes Proforma
is a particularly useful tool
because what this does
is it asks patients
what their major concern is.
And when we use this measure,
we find that
the two main concerns
that patients have
tend to improve.
So these people are saying
that the problems
that they have are improved
by the weight loss
that we see in our program.